Avid Radiopharmaceuticals clinical trials

Acquired by Eli Lilly and Company, Dec 20, 2010 · source ↗

The registry lists 54 studies whose lead sponsor is Avid Radiopharmaceuticals. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 10, 2025.

• 54studies on the registry
• 0open to participants now

Studies

Recruiting first, then most recently updated. Showing 50 of 54. List all 54 → · All Eli Lilly and Company studies →

• 18F-AV-1451 High Resolution Autopsy StudyCompletedNCT02350634Phase 1

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07CompletedNCT01447719Phase 3

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• 18F-LY3950321-01 Biodistribution and Safety StudyCompletedNCT05775601Early Phase 1

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)CompletedNCT01565382Phase 3

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Early Clinical Evaluation of 18F-LY3546117 in Tumor ImagingStatus unknownNCT04721756Early Phase 1

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Flortaucipir 18F PET Imaging in BIOCARD StudyTerminatedNCT03052972Phase 1

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Flortaucipir PET Imaging in Subjects With FTDCompletedNCT03040713Phase 1

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired SubjectsCompletedNCT04474405Early Phase 1

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's DiseaseCompletedNCT04468347Phase 1

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD SubjectsCompletedNCT02016560Phase 2/3

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Clinical Evaluation of Flortaucipir F 18CompletedNCT02278367Phase 2

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Tau Imaging in Professional FightersCompletedNCT02278354Phase 1

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan InterpretationCompletedNCT03901092Phase 3

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired SubjectsCompletedNCT01992380Phase 1

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• 18F-AV-1451 Autopsy StudyCompletedNCT02516046Phase 3

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• 18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic EncephalopathyCompletedNCT02079766Phase 2

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Imaging Characteristics of a Follow-up 18F-AV-1451 ScanTerminatedNCT02051764Phase 2

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy VolunteersCompletedNCT02167594Phase 1

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's DiseaseCompletedNCT03901105Phase 3

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05CompletedNCT02795780Phase 2

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Tau Screening Study in Patients With Early Symptomatic ADCompletedNCT03322462Phase 2

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Tau Screening Study in Subjects With Early Symptomatic ADCompletedNCT03467477Phase 2

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Augmenting Flortaucipir Dosimetry EstimatesCompletedNCT02336360Phase 1

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• A Trial of 18F-AV-133 Positron Emission Tomography (PET)TerminatedNCT01515384Phase 1

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research TrialsCompletedNCT02918539

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Clinical Evaluation of Florbetapir F 18 (18F-AV-45)CompletedNCT01518374Phase 2

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Florbetapir Calibration to the Centiloid ScaleCompletedNCT02120664Phase 1

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement DisordersCompletedNCT01550484Phase 2/3

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive DeclineCompletedNCT01703702Phase 4

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• 18F-AV-1451 PET Imaging in TBIWithdrawnNCT02512029Phase 1

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy ControlsCompletedNCT01710371Phase 1

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Evaluation of Reader Training ProcessesCompletedNCT02051790Phase 4

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• The Feasibility of Florbetapir Quantitation in EuropeCompletedNCT02107599Phase 4

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• The Feasibility of Florbetapir QuantitationCompletedNCT01946243Phase 4

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese PhysiciansWithdrawnNCT02029547Not applicable

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.CompletedNCT01890343Phase 2

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)CompletedNCT01662882Phase 2/3

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• A Study of Florbetapir (18F) in Japanese Healthy VolunteersCompletedNCT01660815Phase 1

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807TerminatedNCT01733355Early Phase 1

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808TerminatedNCT01723488Early Phase 1

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive DeclineCompletedNCT01400425Phase 3

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)CompletedNCT00857506Phase 2

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted before Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease PatientsCompletedNCT00857532Phase 2

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted before Avid Radiopharmaceuticals became part of Eli Lilly and Company

• A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)CompletedNCT01503944Phase 1/2

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted before Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal IndividualsCompletedNCT00855868Phase 2

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted before Avid Radiopharmaceuticals became part of Eli Lilly and Company

• A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy VolunteersCompletedNCT01565330Phase 1

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Evaluation of Physician Training Methods to Read Florbetapir-PET ScansCompletedNCT01565369Not applicable

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET ScansCompletedNCT01550549Not applicable

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Evaluation of PET Scan Timing Relative to AV-45 Injection TimeCompletedNCT01565356Not applicable

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted after Avid Radiopharmaceuticals became part of Eli Lilly and Company

• Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the BrainCompletedNCT00857415Phase 3

  Sponsor listed in the registry: Avid Radiopharmaceuticals · First submitted before Avid Radiopharmaceuticals became part of Eli Lilly and Company